Heterogeneity in hormone-dependent breast cancer and therapy: Steroid hormones, HER2, melanoma antigens, and cannabinoid receptors
Breast cancer is the most frequently diagnosed cancer and the leading cause of death by cancer among women worldwide. The prognosis of the disease and patients’ response to different types of therapies varies in different subgroups of this heterogeneous disease. The subgroups are based on histologic...
Main Authors: | Tajda Tavčar Kunstič, Nataša Debeljak, Klementina Fon Tacer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | Advances in Cancer Biology - Metastasis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667394022000600 |
Similar Items
-
Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment
by: Luka Dobovišek, et al.
Published: (2020-02-01) -
Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro
by: Georg Richtig, et al.
Published: (2023-05-01) -
Molecular Mechanism of Autophagy and Its Regulation by Cannabinoids in Cancer
by: Xin Chien Lee, et al.
Published: (2021-03-01) -
Marijuana and the cannabinoids /
by: ElSohly, Mahmoud A.
Published: (2007) -
The use of cannabinoids in epilepsy as an example: medical, social, and legal aspects
by: R. G. Akzhigitov, et al.
Published: (2020-08-01)